Inspire Medical Systems Inc (INSP): Enterprise Value to EBITDA Ratio
Inspire Medical Systems management is currently adjusting its commercial plan to align with new insurance conditions, which is supported by the EV/EBITDA metric accounting for debt and amortization. The 45.43 mark reflects the latest data. The global expansion of apnea therapy systems in Asia and Europe mitigates local risks, although trade barriers and microchip supply disruptions complicate the export of implants.
Comprehensive metric breakdowns and analytics for inspiresleep.com (INSP)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Inspire Medical Systems|INSP - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Inspire Medical Systems, Inc.|INSP - Company Total Debt|Debts to Book Capitalization Inspire Medical Systems Inc|INSP - Long-Term Debt|Company Short-Term Debts Inspire Medical Systems|Quick Ratio inspiresleep.com
- financial results and valuation multiples details:
INSP - Net Financial Result|Projected Future Earnings Inspire Medical Systems|INSP - Price to Earnings Ratio|Forward P/E Multiple Inspire Medical Systems|INSP - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Inspire Medical Systems Inc|INSP - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Inspire Medical Systems|INSP - Earnings per share for the trailing year|Quarterly EPS earnings growth inspiresleep.com|INSP - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Inspire Medical Systems
Analysis of all company metrics:Inspire Sleep INSP
High R&D expenditures by Inspire Medical Systems (INSP) for the development of smart devices necessitate strict control over debt load, making the EV/EBITDA metric critical for analyzing the business's real value relative to operating profit. The current value of 45.43 allows investors to filter out speculative noise from fundamental growth, assessing the company's valuation trend via EV/EBITDA as an indicator of capitalization resilience to interest payments.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|PRCT: EV/EBITDA Multiple|CNMD - Total Company Value to Operating Income Before Depreciation Ratio|PLSE (Pulse Corp) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio InMode MD (INMD)|Enterprise Value to EBITDA Ratio PMI (Picard Medical Inc)|SRDX (surmodics.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Senseonics Holdings Inc SENS|NPCE - Enterprise Value to EBITDA Ratio|Tactile Systems Technology Inc. - EV/EBITDA Multiple|Company Value to EBITDA SANUWAVE Health Inc|OM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ELMD|LNSR (LENSAR) - EV/EBITDA Multiple|AVITA Medical Inc. (RCEL) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PROF|Enterprise Value to EBITDA Ratio bairdmed.com BDMD|EV/EBITDA Multiple EDAP (EDAP TMS)|EV/EBITDA Multiple Apyx Medical Corp APYX|ICCM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TELA (telabio.com) - Enterprise Value to EBITDA Ratio|CytoSorbents Corporation - Business Value to Operating Income Before Depreciation|SRTS (Sensus Healthcare, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA zynex.com ZYXI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization electroCore, Inc. (ECOR)|vicarioussurgical.com (RBOT) - Enterprise Value to EBITDA Multiple|Inspira Technologies - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple SeaStar Medical Holding Corp. ICU|IRIDEX Corp. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Intelligent Bio Solutions INBS|beyondair.net (XAIR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio PFSA (Profusa Inc.)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization STRATA Skin Sciences Inc.|Enterprise Value to EBITDA Ratio GlucoTrack Inc. (GCTK)|EV/EBITDA Multiple NAOV|VERO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nuwellis NUWE|AEMD: Enterprise Value to Operating Income Before Depreciation|ASXC: Enterprise Value to EBITDA Ratio|Avinger Inc - Enterprise Value to Operating Income Before Depreciation Ratio|BSGM: EV/EBITDA Multiple|CUTR - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Know Labs|Enterprise Value to Operating Income Before Depreciation NARI (Inari Medical Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Corporation (NVRO)|Total Company Value to Operating Income Before Depreciation Ratio reshapelifesciences.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Silk Road Medical, Inc SILK
